<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04757753</url>
  </required_header>
  <id_info>
    <org_study_id>20/001</org_study_id>
    <secondary_id>2020-A01790-39-PP</secondary_id>
    <secondary_id>CIV-BE-20-10-034945</secondary_id>
    <nct_id>NCT04757753</nct_id>
  </id_info>
  <brief_title>Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial</brief_title>
  <acronym>OPTIFILL</acronym>
  <official_title>Evaluation of the Efficacy Rate of Endodontic Treatment at 2 Years After Root Canal Filling With a Ready-to-use Root Canal Sealer PA1704 Versus BioRoot™ RCS: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Septodont</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Slb Pharma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Septodont</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects&#xD;
      (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups&#xD;
      (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2&#xD;
      years after root canal obturation undertaken using a ready-to-use calcium silicate sealer&#xD;
      (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS.&#xD;
&#xD;
      Procedures of root canal treatment will be conventional and standardized for all&#xD;
      investigational centers. The canals will be cleaned, shaped and then obturated using a&#xD;
      calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone&#xD;
      technique or cold lateral condensation of gutta-percha. Follow-up assessments will be&#xD;
      conducted at 6, 12 and 24 months. Retroalveolar radiographs will be taken at each study&#xD;
      visit. The preoperative, postoperative and follow-up clinical and radiographic data will be&#xD;
      analyzed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 6, 2020</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study subject (tooth) will be randomized in a 1:1 allocation ratio between the 2 treatment groups; the allocation will be stratified by the endodontic indication, i.e. primary or secondary root canal treatment, to enhance balance.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Blinding will be done to the assessors who analyzed radiographs to reduce bias to healing assessment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy rate of root canal obturation</measure>
    <time_frame>24 months post-treatment</time_frame>
    <description>Efficacy rate of root canal obturation using clinical and radiological criteria. The radiographic criterion will be assessed by blinded evaluators. The efficacy rates will be compared between the 2 groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy rate of root canal obturation</measure>
    <time_frame>6, 12 months post-treatment</time_frame>
    <description>Efficacy rate of root canal obturation using clinical and radiological criteria. The radiographic criterion will be assessed by blinded evaluators. The efficacy rates will be compared between the 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiological evaluation of the canal obturation</measure>
    <time_frame>baseline, 6-, 12- and 24-months post-treatment</time_frame>
    <description>Radiological evaluation of the level of apical obturation and density</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7.</time_frame>
    <description>The pain is assessed by patients in a diary using a Visual Analogue Scale (VAS: 0-100 mm) at different times after endodontic treatment (at the end of the root canal obturation, 12h postoperative, 24h, Day 2, Day 3, Day 7). The maximum pain felt will be compared between the 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of oral pain treatment</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to Day 7</time_frame>
    <description>Patients reported the consumption of analgesic treatment in a diary. The proportion of patients who took oral pain medication and the treatment categories will be compared between the 2 groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>from the end of the root canal treatment (Day 0) to 24 months</time_frame>
    <description>Adverse events reported by patients on a diary from Day 0 to Day 7 and adverse events clinically observed by the dental surgeon at each follow-up visit will be used to assess the safety of root canal sealers and endodontic procedures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Root Canal Obturation</condition>
  <arm_group>
    <arm_group_label>ready-to-use root canal sealer: PA1704</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PA1704 is used in combination with gutta percha points for the permanent obturation of root canals.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>root canal sealer: BioRoot™ RCS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BioRoot™ RCS is used in combination with gutta percha points for the permanent obturation of root canals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ready-to-use root canal sealer: PA1704</intervention_name>
    <description>The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha.</description>
    <arm_group_label>ready-to-use root canal sealer: PA1704</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>root canal sealer: BioRoot™ RCS</intervention_name>
    <description>The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha.</description>
    <arm_group_label>root canal sealer: BioRoot™ RCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult male or female (age ≥ 18 years)&#xD;
&#xD;
          -  Patient requiring a primary or a secondary root canal obturation on a single or&#xD;
             multi-rooted tooth,&#xD;
&#xD;
          -  Patient geographically stable who can be followed by the same investigator site for 2&#xD;
             years,&#xD;
&#xD;
          -  Informed consent signed,&#xD;
&#xD;
          -  Patient with social protection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with one or more documented contraindication to endodontic treatment,&#xD;
&#xD;
          -  Contraindication to the use of calcium silicate root canal sealer, such as an immature&#xD;
             tooth or a known hypersensitivity to one component of the sealer formula,&#xD;
&#xD;
          -  Endodontic treatment on tooth with calcified root canal assessed radiographically,&#xD;
&#xD;
          -  Endodontic treatment on tooth with suspected perforation,&#xD;
&#xD;
          -  Patient with an uncontrolled systemic disease such as diabetes or thyroid disorders,&#xD;
             or with an immunocompromised condition or who has undergone radiation therapy to the&#xD;
             jaw.&#xD;
&#xD;
          -  Patient suffering from uncontrolled active periodontitis, not supported&#xD;
&#xD;
          -  Participation to another interventional clinical study at the same time,&#xD;
&#xD;
          -  Vulnerable subjects referred to in articles L.1121-5 to 8 and L.1122-1-2 of the Public&#xD;
             Health Code and article 66 of Regulation (EU) 2017/745 on medical devices are excluded&#xD;
             from the investigation (such as known pregnancy or lactation, patients with legal&#xD;
             protection).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane Simon, Pr, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cabinet dentaire Jeanne d'Arc - ROUEN (76000) - France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc, Département de Médecine Dentaire et de Stomatologie</name>
      <address>
        <city>Bruxelles</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de santé dentaire Flandre</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire Jeanne d'Arc</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cabinet dentaire</name>
      <address>
        <city>Saint-Grégoire</city>
        <zip>35760</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 12, 2021</study_first_submitted>
  <study_first_submitted_qc>February 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>September 28, 2021</last_update_submitted>
  <last_update_submitted_qc>September 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>endodontic treatment</keyword>
  <keyword>root canal sealer</keyword>
  <keyword>periapical lesion</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

